Buckley Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Buckley Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$38.5 - $76.05 $192,500 - $380,250	-5,000 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$35.45 - $48.2 $177,250 - $241,000	5,000 New	5,000 $236,000
Q4 2018 Feb 01, 2019	SELL	$22.73 - $42.34 $113,650 - $211,700	-5,000 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$44.35 - $65.71 $221,750 - $328,549	5,000 New	5,000 $222,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Buckley Wealth Management, LLC with notifications on news.